| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 80.70B | — |
| Operating expense | — | — |
| Net income | 4.43B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, DRREDDY.NS returned -6.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -5.8% |
| 1 year | -6.3% |
| 5 years | +30.8% |
| 10 years | +106.1% |
| All-time high | ₹1,406.27 (Aug 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in DRREDDY.NS would be worth today ›Yes. Dr. Reddy's Laboratories Limited paid 1 dividend over the past 12 months. The most recent was ₹8.00 per share on Jul 10, 2026. The dividend yield is 0.68%.
Dr. Reddy's Laboratories Limited is part of the Healthcare sector.
Dr. Reddy's Laboratories Limited has a market cap of 991.27B INR, based on the latest quote.
Dr. Reddy's Laboratories Limited is scheduled to report earnings on Oct 22, 2026.
